NEW YORK — The S&P 500 closed at 7,753, down 0.1 percent, even as 17 constituent companies posted strong revenue growth and expanding profit margins. This cohort is outperforming the broader market by managing costs and optimizing operations.
Data from MacroMicro shows the market-cap share of the top 10 S&P 500 constituents has risen steadily since 2015, with concentration jumping sharply after 2020. A growing share of total index value now resides in a handful of firms.
Eli Lilly stands out. Its GLP-1 therapies for diabetes and obesity have driven a step-change in revenue, with product innovation translating directly into top-line expansion.
Newmont also features in the group, benefiting from favorable commodity prices. Efficient extraction processes have widened its profit margins.
Southwest Airlines has improved margins through optimized routes and tight cost management, allowing the carrier to improve profitability as travel demand holds.
Across these companies, disciplined cost control and strategic product mix have driven operating margin expansion through varying market cycles, regardless of sector.
This earnings season makes one thing clear for investors: revenue growth alone is insufficient. Sustainable profitability requires expanding and maintaining strong profit margins.
As market value concentrates in these high performers, their financial health carries greater weight for the overall index—a dynamic that complicates traditional diversification strategies. Among the 17 firms, some trade at valuations that still offer entry points for investors seeking durable margin-led returns.
